Merkel cell polyomavirus DNA in CSF of paediatric patients with suspected meningitis or encephalitis.

Authors

Negar Hemmati, Fatemeh Hoda Fallah, Bahman Abedi Kiasari

Published in

Virology journal. Volume 23. Issue 1. Jul 25, 2026. Epub Jul 25, 2026.

Abstract

The clinical significance of Merkel cell polyomavirus (MCPyV) in pediatric central nervous system (CNS) infections remains uncertain, particularly in immunocompromised children.
To determine the frequency of MCPyV DNA in cerebrospinal fluid (CSF) from children with suspected viral meningitis or encephalitis and evaluate its association with HIV infection, CSF findings, and clinical outcomes.
CSF samples from 46 pediatric patients with suspected viral CNS infection were analyzed using TaqMan probe-based quantitative PCR targeting the large T-antigen gene. Positive specimens were confirmed by amplification of an independent VP1 target and bidirectional Sanger sequencing following conventional PCR re-amplification. Clinical, laboratory, and outcome data were compared using appropriate statistical tests.
MCPyV DNA was detected in 6/46 patients (13.0%), all of whom were HIV-positive (p = 0.001; sensitivity analysis excluding patients with unknown HIV status, p = 0.002). Four isolates belonged to genotype I and two to genotype IIc. Compared with MCPyV-negative patients, MCPyV-positive patients had higher CSF lymphocyte percentages (89% vs. 84%; p = 0.048), higher protein concentrations (79 vs. 68 mg/dL; p = 0.022), lower glucose concentrations (51 vs. 55 mg/dL; p = 0.038), and more frequent altered consciousness (83.3% vs. 37.5%; p = 0.039). EBV DNA co-detection was identified in one MCPyV-positive patient.
MCPyV DNA was detected exclusively in HIV-positive children and was associated with inflammatory CSF abnormalities. These findings suggest a possible association between MCPyV detection, immunosuppression, and CNS inflammation but do not establish causality. Larger multicenter studies are required.

PMID:
42902299
Bibliographic data and abstract were imported from PubMed on 21 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.